Get started
Author

Lynda Grine

Observed names: Grine, L., Grine, Lynda, L Grine, L. Grine
ORCID: 0000-0002-7546-4454
Observed ORCID: 0000-0002-7546-4454
OpenAlex ID: A5045658215
Gut–Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions
2021 · Britta De Pessemier, Lynda Grine, et al. · Microorganisms · 661
PDF
An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17
2014 · Lynda Grine, Lien Dejager, et al. · Cytokine & Growth Factor Reviews · 201
The many faces of interleukin-17 in inflammatory skin diseases
2016 · R. Speeckaert, J. Lambert, et al. · British Journal of Dermatology · 95
Clinical visible signs of disease activity in vitiligo: a systematic review and meta‐analysis
2019 · N. van Geel, L. Grine, et al. · Journal of the European Academy of Dermatology and Venereology · 80
PDF
TNFR1-induced lethal inflammation is mediated by goblet and Paneth cell dysfunction
2014 · F Van Hauwermeiren, R E Vandenbroucke, et al. · Mucosal Immunology · 51
PDF
Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice
2015 · Lynda Grine, Lien Dejager, et al. · The Journal of Immunology · 47
PDF
Topical imiquimod yields systemic effects due to unintended oral uptake
2016 · Lynda Grine, Sophie Steeland, et al. · Scientific Reports · 42
PDF
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
2019 · L. Grine, M. de la Brassinne, et al. · Journal of the European Academy of Dermatology and Venereology · 41
PDF
Standardizing serial photography for assessing and monitoring vitiligo: A core set of international recommendations for essential clinical and technical specifications
2019 · Nanja van Geel, Iltefat Hamzavi, et al. · Journal of the American Academy of Dermatology · 36
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study
2021 · Lara S. van der Schoot, Juul M. P. A. van den Reek, et al. · Trials · 24
PDF
Therapeutic patient education and self‐management support for patients with psoriasis – a systematic review
2019 · Corinna Dressler, Jo Lambert, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 24
PDF
Towards the development of a RNA i‐based topical treatment for psoriasis: Proof‐of‐concept in a 3D psoriasis skin model
2017 · Eline Desmet, Mireille Van Gele, et al. · Experimental Dermatology · 23
Validation of a physician global assessment tool for vitiligo extent: Results of an international vitiligo expert meeting
2019 · Nanja van Geel, Albert Wolkerstorfer, et al. · Pigment Cell & Melanoma Research · 21
PDF
Reference method for digital surface measurement of target lesions in vitiligo: a comparative analysis
2018 · N. Geel, D. Vandendriessche, et al. · British Journal of Dermatology · 19
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis: results of a structured survey
2020 · Lisa Schots, Lynda Grine, et al. · Journal of Dermatological Treatment · 17
PDF
Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly
2018 · Sofie Mylle, Lynda Grine, et al. · American Journal of Clinical Dermatology · 16
Psoriasis: burning down the host
2015 · Lynda Grine, Jo Lambert · Journal of Dermatological Treatment · 16
PDF
Image analysis systems to calculate the surface area of vitiligo lesions: A systematic review of measurement properties
2022 · Nanja van Geel, Imke Saeys, et al. · Pigment Cell & Melanoma Research · 15
PDF
Validation of a Patient Global Assessment for extent, severity and impact to define the severity strata for the Self Assessment Vitiligo Extent Score (SA‐VES)
2020 · N. van Geel, S.E. Uitentuis, et al. · Journal of the European Academy of Dermatology and Venereology · 15
PDF
The Effects of Modified Intermittent Fasting in Psoriasis (MANGO): Protocol for a Two-Arm Pilot Randomized Controlled Open Cross-over Study
2020 · Lynda Grine, Niels Hilhorst, et al. · JMIR Research Protocols · 14
Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis: A Step toward Personalized Therapy
2019 · Rani Soenen, Evelyn Meulewaeter, et al. · Journal of Investigative Dermatology · 14
PDF
Antisense oligonucleotides against TNFR1 prevent toxicity of TNF/IFNγ treatment in mouse tumor models
2014 · Filip Van Hauwermeiren, Roosmarijn E. Vandenbroucke, et al. · International Journal of Cancer · 14
PDF
Promising Tools to Facilitate the Implementation of TDM of Biologics in Clinical Practice
2022 · Rani Soenen, Christophe Stove, et al. · Journal of Clinical Medicine · 12
PDF
Patient-Relevant Outcomes in Psoriasis
2022 · Niels Hilhorst, Elfie Deprez, et al. · JAMA Dermatology · 11
Comparison of Personality Traits among Patients with Psoriasis, Atopic Dermatitis, and Stress: A Pilot Study
2020 · Lynda Grine, Giulia Tochtermann, et al. · Dermatology · 11
Works count: 60
Citation count: 1,578
H-index: 16
I10-index: 26
Year
Topic
Type